Company Overview of Premune AB
Premune AB, an animal health company, develops treatments for allergies, inflammatory bowel diseases, and other immune disorders in pets worldwide. Its developments are targeting problem areas in veterinary medicine. The company was founded in 2009 and is based in Stockholm, Sweden.
Kungsgatan 3 vån 4
Stockholm, 111 43
Founded in 2009
Key Executives for Premune AB
Co-Founder and Chief Executive Officer
Head of Licensing & Regulatory Affairs and Director
Head of Clinical Development
Head of Regulatory Affairs
Compensation as of Fiscal Year 2016.
Premune AB Key Developments
Premune Signs Licensing Agreement with Innovet Italia
Mar 21 16
Premune AB and Innovet Italia s.r.l. have signed an exclusive licensing agreement for six additional products, targeting three key areas in companion animal well-being. Premune and Innovet Italia are animal health companies based in Sweden and Italy, respectively. The extended product range includes Retopix(R) Spray, Retopix(R) Fluid, and Retopix(R) Oto (skin care), Normalia (R) (support of gut function) and Oculvet(R) Wipes and Oculvet(R) Drops (eye care). America. The expanded collaboration gives Premune exclusive marketing rights for key European countries, with the option to expand to other geographies including North America.
Premune Appoints Ed Torr as Head of Business Development and Commercial Operations
Sep 16 15
Premune announced the appointment of Ed Torr as Head of Business Development and Commercial Operations, effective September 7, 2015. Mr. Torr, who will be based in the UK, will oversee Premune's commercialization and business development efforts as the company prepares for its initial product launches. Ed brings more than 30 years of experience in animal health with senior leadership roles in some of the most prominent animal health companies in Europe including ICI, Coopers Animal Health, Alfa Laval Agri and Dechra Pharmaceuticals PLC. He was an executive director of Dechra Pharmaceuticals PLC from 2000-2014 during which time he had responsibility for business development, manufacturing and product development, Dechra Veterinary Products Europe and geographical expansion.
Premune AB Enters into Licensing Agreement with Innovet Italia s.r.l
Aug 31 15
Premune AB and Innovet Italia s.r.l. have entered into an exclusive licensing agreement for Redonyl (R) Ultra. Redonyl (R) Ultra is a nutritional supplement based on PEA-um (R) (ultramicronized palmitoylethanolamide) to support healthy skin in dogs and cats.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries